Article Details

mAbxience Expanding Biosimilar and CDMO Manufacturing Capacity with ABEC 4000 Liter Single ...

Retrieved on: 2021-03-23 13:41:15

Tags for this article:

Click the tags to see associated articles and topics

mAbxience Expanding Biosimilar and CDMO Manufacturing Capacity with ABEC 4000 Liter Single .... View article details on hiswai:

Excerpt

... in the development, manufacture and commercialization of monoclonal antibodies, and forms part of the pharmaceutical group Insud Pharma.

Article found on: www.kulr8.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up